| Patent Number |
Title Of Patent |
Date Issued |
| 7579380 |
Modified release formulations of a bupropion salt |
August 25, 2009 |
| The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat |
| 7572935 |
Modified release formulations of a bupropion salt |
August 11, 2009 |
| The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat |
| 7553992 |
Modified release formulations of a bupropion salt |
June 30, 2009 |
| The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat |
| 7358399 |
Process for the preparation of N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenyl-propaneamin |
April 15, 2008 |
| A process is described for the preparation of N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenyl-propaneamine comprising substitution of the sulfonyloxy group of the compound of the formula ##STR00001## in which the substituents R and R'' have the meanings stated in the descripti |
| 7332603 |
Preparation of biphosphonic acids and salts thereof |
February 19, 2008 |
| A process for preparing alendronate sodium includes the reaction of gammabutyric acid with phosphorous acid and phosphorus trichioride and subsequent treatment with an aqueous solution of an alkali metal hydroxide, in which the reaction is conducted in liquid ionic solvents. |
| 7241805 |
Modified release formulations of a bupropion salt |
July 10, 2007 |
| The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat |
| 7105681 |
Process for the preparation of sulphinyl derivatives by oxidation of the corresponding sulfides |
September 12, 2006 |
| Process for preparing sulfinyl derivatives of Formula 2, useful as inhibitors of gastric acid secretion, comprising the selective oxidation of the corresponding sulfides of formula 1, as represented in the following scheme ##STR00001## The oxidation is performed with hydrogen peroxid |
| 6897339 |
Process for the production of high purity iohexol |
May 24, 2005 |
| Purification process of iohexol comprising the treatment of said product with 1-methoxy-2-propanol either alone or mixed with other solvents. |
| 6645742 |
Purifying process for phosphatidylserine |
November 11, 2003 |
| The present invention relates to a purifying process for phosphatidylserine, the latter being prepared by trans-phosphatidylation of phosphatidylcholine with serine in presence of the enzyme D-phospholipase and containing as impurities hydrophilic compounds, proteins and inorganic sa |
| 6444822 |
Process for the preparation of 3-substituted 4-phenyl-piperidine derivative |
September 3, 2002 |
| Described herein is the process for the preparation of 3-substituted 4-phenyl-piperidine derivatives of formula (I) ##STR1##in which X is selected from H and F, and R is selected from the group consisting of H, C1-C6 alkyl, C3-C6 alkenyl, and benzyl, comprising three steps starting f |
